Back to Subject Index | Return to Arthritis & Rheumatism Table of Contents Page
- Obituary: Smyth, Charley J., 571
- Occupational hazards
- quartz/metal dust exposure and risk of SSc, 1306
- solvent exposure and risk of SSc, 1111
- Ochronosis (alkaptonuria), and OA, 1895
- 1,25-OH-cholecalciferol (1,25-OH-CCF), effect on monocytes, 2032
- Oligoarthritis
- associated with acne and pustulosis, 1889
- Chlamydia trachomatis in, 845
- Oligonucleotides, CD44 antisense inhibition of, and cartilage chondrolysis, 1411
- Oncostatin M (OSM), and cartilage collagen destruction, 1760
- Opioids, for pain in rheumatic diseases, 1603
- Ossification, heterotopic (HO), in critically ill patients, 1329
- Osteoarthritis (OA)
- alkaptonuria (ochronosis) and, 1895
- cathepsin and matrix metalloproteinase expression in RA and, 1378
- CD88 on synovial mast cells in, 233
- chondrocyte apoptosis in, 285, 1266, 1632
- chondrocytes, inflammation mediators in, 2165
- collagenase inhibitor Ro 32-3555 in murine, 1639
- collagenase 1 and 3 expression in guinea pig, 877
- cyclooxygenase isoforms in, 122
- familial aggregation of, 1227
- Fas/Fas ligand in, 657
- hemiparalysis, impact on expression of, 2249
- hip, and vitamin D receptor, COL1A1, and COL2A1 gene polymorphisms in postmenopausal women, 1946
- hip, avocado/soybean unsaponifiables efficacy in, 81
- hip, prevalence estimates by three radiographic scoring systems, 361
- hip, prevention update, 1343
- hprt mutant T cells in, 1772
- inheritance patterns in, 1064, 1227
- intraarticular hyaluronan in canine, 976
- knee, avocado/soybean unsaponifiables efficacy in, 81
- knee, estrogen replacement therapy and, 1867
- knee, hyaluronan, adduction moment, and disease severity in, 1233
- knee, postmeniscectomy, 687
- knee, quadriceps weakness as risk factor in, 1951
- knee, prevention update, 1343
- MRI of cartilage in, 963
- NO synthase inhibition and, 1275
- phenotype of human osteoblast-like cells in, 891
- prevalence in United States, 778
- Ro 32-3555 in murine, 1639
- transforming growth factor β1 and parathyroid hormone-related protein and, in articular chondrocytes, 2152
- type VI collagen in, 986
- type X collagen in articular cartilage and, 1287
- Osteoblasts, in altered phenotype of human OA, 891
- Osteonecrosis, steroid treatment and, 1709
- Osteoporosis (OP)
- bone densitometry, 577
- corticosteroid-induced, in SLE, 171
- polymorphism in collagen I α1 associated with, 187
- Ovaries, failure in cyclophosphamide-treated SLE, 831
- Oxycodone, and codeine for pain in rheumatic diseases, 1603




